论文部分内容阅读
Background: It is the hot issue that targeting therapy and reversing multidrug resistance are used to improve therapeutic effect and reduce side effect.Combination of two or more therapeutic approaches with different mechanisms is a promising strategy for effective treatments of cancers with synergistic or combined effects.Co-delivery of siRNA and chemotherapeutic agents within a single nanoparticle has been developed to combat multidrug resistance in cancer therapy.